{
  "id": 13111783,
  "title": "Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences",
  "url": "https://urgent.news/2026/10/09/eupraxia-pharmaceuticals-to-present-at-upcoming-american-college-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T12:03:13.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/eupraxia-pharmaceuticals-to-present-at-upcoming-american-college-of-gastroenterology-acg-and-united-european-gastroenterology-ueg-medical-conferences"
  },
  "original_language": "en",
  "account": null,
  "summary": "VANCOUVER, British Columbia, Oct. 09, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today is pleased to announce that three abstracts related to…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}